| Islet blood flow in multiple low dose streptozotocin-treated wild-type and inducible nitric oxide synthase-deficient mice. | |
| | |
MedLine Citation:
|
PMID: 10919259 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The present study tested the hypothesis that changes in islet blood perfusion occur during the development of diabetes in the multiple low dose streptozotocin-treated mouse. Streptozotocin (40 mg/kg) or citrate buffer was given ip once daily for 5 consecutive days to wild-type and inducible nitric oxide synthase (iNOS)-deficient C57BL/6 x 129 SvEv hybrid mice. The blood flows were then determined by a microsphere technique. The islet blood perfusion was almost 2-fold higher in wild-type mice treated with streptozotocin than in those given vehicle. Whole pancreatic blood flow was also increased in the streptozotocin-treated wild-type mice. In iNOS-deficient mice, neither islet blood flow nor whole pancreatic blood flow was affected by repeated streptozotocin treatment. These combined findings suggest an increased islet blood perfusion in the prediabetic stage mediated by an iNOS-dependent mechanism. In combination with increased vasopermeability and expression of adhesion molecules on the islet endothelium, as previously described, this increased islet blood flow may be of crucial importance for the recruitment of inflammatory cells into the islets during the development of diabetes in this animal model. Indeed, an increased degree of insulitis was observed in wild-type mice compared with mice deficient in iNOS as well as a more rapid decrease in islet volume and an earlier debut of manifest diabetes. We also describe altered islet blood perfusion in the iNOS-deficient mice during basal conditions due to a compensatory increase in constitutive NOS activity. |
| | |
Authors:
|
P O Carlsson; M Flodström; S Sandler |
Related Documents
:
|
15105649 - The pancreatic duct and its arteriovenous relationship: an underutilized aid in the dia... 8214079 - Evaluation and validation of microsphere technique for determination of pancreatic bloo... 2868599 - Ablation of serotonergic nerves in the rat pancreas. lack of effects on hormone secreti... 573439 - Exocrine ductal pco2 in the rabbit pancreas. 10385069 - Effect of pancreastatin on cerulein-stimulated pancreatic blood flow and exocrine secre... 6856989 - Experimental pancreatitis in the rat. changes in pulmonary phospholipids during sodium ... 20334409 - Drop production and tip-streaming phenomenon in a microfluidic flow-focusing device via... 1253899 - Effect of air ionization of blood serotonin in vitro. 824719 - Carcinoembryonic antigen and cystic fibrosis protein in blood from cystic fibrosis homo... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Endocrinology Volume: 141 ISSN: 0013-7227 ISO Abbreviation: Endocrinology Publication Date: 2000 Aug |
Date Detail:
|
Created Date: 2000-08-16 Completed Date: 2000-08-16 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0375040 Medline TA: Endocrinology Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 2752-7 Citation Subset: AIM; IM |
Affiliation:
|
Department of Medical Cell Biology, Uppsala University, Sweden. per-ola.carlsson@medcellbiol.uu.se |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Blood Glucose / metabolism Colon / blood supply Diabetes Mellitus, Experimental / physiopathology* Duodenum / blood supply Ileum / blood supply Islets of Langerhans / blood supply*, drug effects Male Mice Mice, Inbred C57BL Nitric Oxide Synthase / deficiency* Nitric Oxide Synthase Type II Pancreas / blood supply, drug effects Streptozocin / administration & dosage* |
| Chemical | |
Reg. No./Substance:
|
0/Blood Glucose; 18883-66-4/Streptozocin; EC 1.14.13.39/Nitric Oxide Synthase; EC 1.14.13.39/Nitric Oxide Synthase Type II; EC 1.14.13.39/Nos2 protein, mouse |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Insulin-like growth factor I reduces ubiquitin and ubiquitin-conjugating enzyme gene expression but ...
Next Document: Role of winged helix transcription factor (WIN) in the regulation of Sertoli cell differentiated fun...